Other examples include reduced survival of sEH-KO mice following cardiac arrest and cardiopulmonary resuscitation [50] and increased albuminuria in mice with progressive renal disease upon pharmacological sEH inhibition [51]. Here, EPHX2 is linked to kidney disorder.